The effectiveness of vitrectomy co-adjuvant intravitreal dexamethasone implant on visual outcome in patients with proliferative diabetic retinopathy: study protocol for a prospective randomized controlled trial
The trial was registered at the Chinese Clinical Trial Registry on May 11, 2022, with registration number ChiCTR2200059760.
Authors
- Jun Xu (ORCID: https://orcid.org/0000-0001-7432-6781)
- Aman Chandra (ORCID: https://orcid.org/0000-0003-4073-0238)
- Zhaoyang Wang (ORCID: https://orcid.org/0000-0002-3124-7060)
- Lin Liu (ORCID: https://orcid.org/0000-0002-4613-3998)
- Meng Zhao (ORCID: https://orcid.org/0000-0003-2049-9147)
- Jipeng Li (ORCID: https://orcid.org/0009-0003-2141-5782)
Institutions
- Beijing Tongren Hospital (CN)
- Southend University Hospital NHS Foundation Trust (GB)
- Anglia Ruskin University (GB)
Publication Details
- Journal
- Trials
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1186/s13063-025-08758-1
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71